REXAHN PHARMACEUTICALS, INC. 10-Q 9-30-2014

Company

Opus Genetics, Inc.

Filed

November 12, 2014

Period of Report

September 30, 2014

Accession Number

0001140361-14-041326

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →